TLX1
Basic information
Region (hg38): 10:101131300-101137789
Previous symbols: [ "TCL3", "HOX11" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 1 | 0 |
Variants in TLX1
This is a list of pathogenic ClinVar variants found in the TLX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-101131563-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
10-101131674-T-C | not specified | Uncertain significance (Feb 14, 2024) | ||
10-101131680-C-A | not specified | Uncertain significance (Nov 30, 2022) | ||
10-101131731-G-A | not specified | Uncertain significance (Sep 22, 2022) | ||
10-101131734-G-T | not specified | Uncertain significance (Mar 12, 2024) | ||
10-101131737-A-C | not specified | Uncertain significance (Jul 09, 2021) | ||
10-101131749-G-A | not specified | Uncertain significance (May 10, 2024) | ||
10-101131777-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
10-101131795-C-G | not specified | Uncertain significance (Jan 04, 2022) | ||
10-101131876-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
10-101131878-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
10-101131896-A-G | not specified | Likely benign (Dec 28, 2022) | ||
10-101131905-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
10-101131941-G-A | not specified | Uncertain significance (May 30, 2024) | ||
10-101131975-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
10-101131978-A-C | not specified | Uncertain significance (Dec 07, 2021) | ||
10-101134217-C-T | not specified | Uncertain significance (Sep 28, 2021) | ||
10-101136717-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
10-101136821-T-C | not specified | Uncertain significance (May 05, 2023) | ||
10-101136891-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
10-101136906-G-T | not specified | Uncertain significance (Mar 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TLX1 | protein_coding | protein_coding | ENST00000370196 | 3 | 8289 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.742 | 0.256 | 123490 | 0 | 2 | 123492 | 0.00000810 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.93 | 85 | 152 | 0.560 | 0.00000709 | 2053 |
Missense in Polyphen | 19 | 52.994 | 0.35853 | 638 | ||
Synonymous | 0.560 | 64 | 70.0 | 0.915 | 0.00000342 | 708 |
Loss of Function | 2.44 | 1 | 8.80 | 0.114 | 3.81e-7 | 110 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000549 | 0.0000546 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000911 | 0.00000910 |
Middle Eastern | 0.0000549 | 0.0000546 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Controls the genesis of the spleen. Binds to the DNA sequence 5'-GGCGGTAAGTGG-3'.;
- Disease
- DISEASE: Note=A chromosomal aberration involving TLX1 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(10;14)(q24;q11) with TCRD. {ECO:0000269|PubMed:1676542, ECO:0000269|PubMed:1681546, ECO:0000269|PubMed:1717256}.;
- Pathway
- Transcriptional misregulation in cancer - Homo sapiens (human);Cell Differentiation - Index expanded;Cell Differentiation - Index
(Consensus)
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- loftool
- 0.138
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.4
Haploinsufficiency Scores
- pHI
- 0.471
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.423
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.891
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tlx1
- Phenotype
- cellular phenotype; hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- multicellular organism development;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding